CanNordic a/s: Financial statements 2017
CVR: 33871902
Source: annual report 2017, Danish Business Authority
01/10/2016 – 30/09/2017
CanNordic a/s (CVR 33871902) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -416,553 and a net result of DKK -570,931 compared with DKK -802,938 the year before. Equity in the 2017 report amounted to DKK -1,830,364.
- Gross Profit
- DKK -416,553
- Profit/Loss
- DKK -570,931
- Equity
- DKK -1,830,364
- Total Assets
- DKK 1,909,946
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | -417 t. | -571 t. | -1.8 mio. | - |
| 2016 | - | -383 t. | -803 t. | -1.3 mio. | - |
| 2015 | - | -84 t. | -542 t. | -456 t. | - |
| 2014 | - | 159 t. | -39 t. | 86 t. | - |
| 2013 | - | 325 t. | 89 t. | 125 t. | - |
Official annual report
Keep an eye on CanNordic a/s
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout CanNordic a/s
CanNordic a/s is a Danish company of the type Aktieselskab based in København Ø, founded in 2011. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named GALAXA PHARMA ApS. The management consists of Lone Henriksen. The board consists of Gitte Henriksen, Jens Jørgen Hagelskjær and Lone Henriksen. The company is owned by CS MEDICA a/s. The company has 1 employee (2016). In 2025, the company reported a gross profit of DKK -100,395 and a net result of DKK -6,219,720 compared with DKK -4,881,640 the year before. Equity in the 2025 report amounted to DKK 4,298,968.